NCT07836803Not yet recruiting
TORCH-LATAM-002: Regional Pathway for Adult Heart Transplant Evaluation and Candidacy
A Stepped-Wedge Cluster Randomized Trial of the TORCH Adult Heart Transplant Evaluation and Candidacy Pathway for Adults With Advanced Heart Failure in Latin America
Source: ClinicalTrials.gov · Last updated 13 Oct 2026
Brief summary (registry, in English)
TORCH-LATAM-002 is a pragmatic stepped-wedge cluster randomized trial evaluating an integrated regional pathway for adults with advanced heart failure who require specialized heart transplant evaluation and a documented candidacy decision. Participating network clusters transition from usual local pathways to the TORCH Adult Heart Transplant Evaluation and Candidacy Pathway. The primary outcome is completion of multidisciplinary evaluation and a documented transplant-candidacy decision within 90 days after enrollment. The study also examines pathway activation, barriers, clinical outcomes, waiting-list trajectories, and traceable donor-organ opportunities. Enrollment does not constitute placement on an official waiting list, organ allocation, or authorization of cross-border care.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 360 (estimated)
- First submitted
- 8 Sept 2026
- Start date
- 30 Mar 2027
- Primary completion date
- 30 Mar 2029
- Lead sponsor
- CardioVision International Tech, S.A.S. de C.V.
- Diseases
- Heart failure
- NCT number
- NCT07836803
What you commit to
- Study type: Interventional
- Planned participants: 360
- From 30 Mar 2027 to the primary completion date, 30 Mar 2029
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- The prespecified multidisciplinary evaluation and transplant-candidacy decision were already completed before the enrollment reference time.
Other illness
- Primary congenital heart disease managed under the pediatric or congenital TORCH protocol.
Other
- No authorized route for protocol evaluation or follow-up at the time of enrollment.
- Unable or unwilling to provide informed consent when required.
Who the study is looking for
- Age 18 years or older.
- Advanced heart failure or acquired or structural heart disease meeting a protocol-defined trigger for specialized heart transplant evaluation.
- Identification within an activated TORCH network cluster with an operational route to at least one authorized transplant center.
- Ability to complete the protocol-defined follow-up directly or through an authorized network pathway.
- Provision of informed consent according to applicable requirements.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.